An economic evaluation of plasma production via erythroplasmapheresis and whole blood collection.
This paper presents cost-effectiveness analyses (CEAs) of plasma collection via two alternative methods: whole blood collection (WBC) and erythroplasmapheresis collection (EPC). The objective of the study is to provide an answer to the question 'What is the least-cost method of plasma production'. This question is answered, both from the viewpoint of the blood collection agency (using financial CEA) and from that of 'society' as a whole (using economic CEA). We employ detailed financial data and economic survey data for collections made by a blood collection agency and to WBC and EPC donors in Brisbane, Australia. The results indicate that, despite the superior yield provided by EPC, WBC is actually more cost-effective. This result is robust to thorough sensitivity analysis and arises regardless of whether an economic or financial perspective is taken. We conclude that, ceteris paribus, the cost of recruiting new plasma donors would need to be quite substantial for marginal investments in EPC to be considered cost-effective.
D001315:Australia; D001771:Blood Banks / Q000191:economics; D001781:Blood Component Removal / Q000191:economics* / Q000379:methods; D001800:Blood Specimen Collection / Q000191:economics / Q000379:methods; D003362:Cost-Benefit Analysis; D006801:Humans; D010949:Plasma; D010956:Plasmapheresis / Q000191:economics / Q000379:methods; D000094902:Blood Banking / Q000379:methods